NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Historical Holders from Q1 2014 to Q1 2025

Symbol
NEO on Nasdaq
CUSIP
64049M209
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
129M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
123M
Holdings value
$2.02B
% of all portfolios
0.004%
Grand Portfolio weight change
0%
Number of holders
248
Number of buys
92
Number of sells
-128
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
INTEGRATED CORE STRATEGIES (US) LLC 5.4% $66M 6.95M Millennium Management LLC Mar 13, 2025
JANUS HENDERSON GROUP PLC 4.8% $58.5M 6.17M JANUS HENDERSON GROUP PLC Dec 31, 2024

Institutional Holders of NEOGENOMICS INC - Common Stock, par value $0.001 per share (NEO)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 812K $7.67M +$595K $9.49 27
2024 Q4 123M $2.02B -$12M $16.48 248
2024 Q3 123M $1.82B -$36.3M $14.75 266
2024 Q2 126M $1.74B -$12.5M $13.87 254
2024 Q1 128M $2.01B +$27.5M $15.72 264
2023 Q4 126M $2.03B +$107M $16.18 278
2023 Q3 117M $1.44B +$29.2M $12.30 273
2023 Q2 116M $1.87B -$1.7M $16.07 258
2023 Q1 116M $2.02B +$68.1M $17.41 249
2022 Q4 112M $1.04B +$6.56M $9.24 230
2022 Q3 109M $938M -$63.5M $8.61 228
2022 Q2 117M $956M +$3.71M $8.15 216
2022 Q1 111M $1.35B -$168M $12.15 259
2021 Q4 116M $3.96B +$18.9M $34.12 297
2021 Q3 114M $5.52B +$214M $48.24 316
2021 Q2 111M $5.02B +$195M $45.17 306
2021 Q1 106M $5.13B +$225M $48.23 324
2020 Q4 102M $5.48B +$118M $53.84 331
2020 Q3 102M $3.75B +$1.21M $36.89 283
2020 Q2 102M $3.17B +$265M $30.98 277
2020 Q1 93.5M $2.58B +$27.5M $27.61 264
2019 Q4 93.3M $2.73B +$45.3M $29.25 253
2019 Q3 85.5M $1.64B -$16.9M $19.12 246
2019 Q2 87.8M $1.93B +$197M $21.94 243
2019 Q1 80.3M $1.64B +$187M $20.46 232
2018 Q4 73.1M $922M -$106M $12.61 204
2018 Q3 78.2M $1.2B +$182M $15.35 163
2018 Q2 65.9M $864M -$4.74M $13.11 141
2018 Q1 67M $547M -$9.86M $8.16 133
2017 Q4 67.6M $599M +$3.69M $8.86 126
2017 Q3 64.8M $721M +$27.8M $11.13 131
2017 Q2 63.8M $572M +$42.5M $8.96 128
2017 Q1 60.8M $480M +$22.1M $7.89 138
2016 Q4 61.5M $527M +$18.9M $8.57 139
2016 Q3 59.9M $492M -$2.1M $8.22 133
2016 Q2 60.1M $483M +$27.7M $8.04 151
2016 Q1 56.6M $382M +$8.01M $6.74 118
2015 Q4 54.9M $432M +$135M $7.87 118
2015 Q3 38.4M $220M +$2.78M $5.73 98
2015 Q2 37.2M $201M +$12.9M $5.41 95
2015 Q1 34.1M $159M +$4.32M $4.67 82
2014 Q4 33.4M $139M -$2.65M $4.17 86
2014 Q3 33.6M $175M +$53M $5.21 85
2014 Q2 23.8M $79.1M +$504K $3.32 67
2014 Q1 23.7M $82.4M +$3.33M $3.47 68